Related Experiment Video
Updated: Aug 7, 2026
06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Viral based gene therapy for prostate cancer
Y Lu1
1Department of Urology, College of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA. ylu@utmem.edu
Current Gene Therapy
|July 12, 2002
Summary
Gene therapy offers new hope for prostate cancer treatment by utilizing advanced viral vectors and targeted gene strategies. This review explores viral gene therapy approaches, clinical trials, and future directions for effective prostate cancer management.
Area of Science:
- Molecular and Cell Biology
- Oncology
- Gene Therapy
Background:
- Gene therapy has advanced significantly due to progress in molecular and cell biology.
- Improvements in gene delivery systems, therapeutic genes, and disease understanding are key.
- Viral gene therapy is a promising avenue for prostate cancer treatment.
Purpose of the Study:
- To review and discuss viral-based gene therapy specifically for prostate cancer.
- To emphasize key aspects including viral vectors, delivery routes, and targeting strategies.
- To explore various therapeutic gene strategies and their applications in prostate cancer.
Main Methods:
- Review of viral vectors and delivery routes for prostate cancer gene therapy.
- Analysis of prostate-targeted viruses and therapeutic gene choices.
- Discussion of gene therapy strategies: corrective, suicide, programmed cell death, immunomodulation, and oncolytic viruses.
Main Results:
- Viral gene therapy offers diverse strategies for prostate cancer, including tumor suppressor gene therapy and suicide gene therapy.
- Prostate-targeted viruses and conditional oncolytic virus approaches show potential.
- Several examples are discussed in detail regarding scientific basis and therapeutic applications.
Conclusions:
- Viral gene therapy presents a multifaceted approach to treating prostate cancer.
- Further research into clinical trials, unresolved problems, and future directions is crucial.
- Advancements in gene therapy hold significant promise for improving prostate cancer outcomes.
More Related Videos
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.